Peers of Amylyx Pharmaceuticals Inc (AMLX)
Side-by-side comparison
Health Care · Pharmaceuticals
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
2758.66x
As of Sep 29, 2025
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Sep 29, 2025 | 2758.66x |
| Sep 26, 2025 | 2677.22x |
| Sep 25, 2025 | 2527.20x |
| Sep 24, 2025 | 2540.06x |
| Sep 23, 2025 | 2454.33x |
| Sep 22, 2025 | 2417.90x |
| Sep 19, 2025 | 2417.90x |
| Sep 18, 2025 | 2405.04x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison